Free Trial

CytomX Therapeutics (CTMX) SEC Filings & 10K Form

CytomX Therapeutics logo
$0.89 +0.02 (+2.30%)
(As of 11/22/2024 ET)

Recent CytomX Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
3:26 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
11/14/2024
2:03 PM
Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G/A
11/14/2024
11:28 AM
CytomX Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G/A
08/22/2024
4:58 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
4:59 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:00 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:01 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:01 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
11:15 PM
CytomX Therapeutics (Filer)
Form EFFECT
06/17/2024
3:35 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2024
4:36 PM
CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:36 PM
CytomX Therapeutics (Issuer)
Young Matthew P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:31 PM
Ashworth Alan (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:32 PM
CytomX Therapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:33 PM
CytomX Therapeutics (Issuer)
Jones Elaine V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:34 PM
CytomX Therapeutics (Issuer)
Meyers James R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:34 PM
CytomX Therapeutics (Issuer)
Mohindru Mani (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:00 PM
Cormorant Asset Management, LP (Filed by)
CytomX Therapeutics (Subject)
Form SC 13G
05/08/2024
3:41 PM
CytomX Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
5:06 AM
CytomX Therapeutics (Filer)
Form DEFA14A
04/04/2024
3:31 PM
CytomX Therapeutics (Filer)
Form DEF 14A
04/04/2024
3:33 PM
CytomX Therapeutics (Filer)
Form DEFA14A
03/28/2024
6:12 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:15 PM
CytomX Therapeutics (Filer)
Form PRE 14A
03/22/2024
3:27 PM
CytomX Therapeutics (Issuer)
Su Zhen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:36 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:37 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:38 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:40 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:41 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:30 PM
CytomX Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/19/2024
7:41 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:43 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:44 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:37 PM
Chu Yu-Waye (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:38 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:40 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:54 PM
BELVIN MARCIA (Reporting)
CytomX Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:55 PM
CytomX Therapeutics (Issuer)
ROWLAND LLOYD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:56 PM
CytomX Therapeutics (Issuer)
Landau Jeffrey B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
6:57 PM
CytomX Therapeutics (Issuer)
McCarthy Sean A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump Wins… But Elon Says Get Ready to Brace (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov
12/19/2023
6:58 PM
CytomX Therapeutics (Issuer)
Ogden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTMX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners